Company / R&D per Share
Revvity R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.79
FY2025
5-year range
$1.59 / $1.79
FY2021-FY2025
Trend
+12.2%
vs FY2024
Sector context
#52 of 108
Health Care
What the data says
At $1.79, Revvity's r&d per share ranks #52 of 108 in the Health Care sector. R&D per Share returned to growth in FY2025 after 3 years of decline, reaching $1.79.
Based on SEC 10-K filings.
1.79 in FY2025 with a 5-year CAGR of +6.3%.
Improved from $1.71 to $1.79 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +0.6%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Sector benchmark
#52 of 108 in Health CareTop 48% of 108This company $1.79 Sector average $2.07
▼
-13.6% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 12.2% year-over-year.
- Ranks #52 out of 108 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.79 | +12.2% |
| FY2024 | $1.59 | -7.0% |
| FY2023 | $1.71 | -2.3% |
| FY2022 | $1.76 | -1.8% |
| FY2021 | $1.79 | +35.6% |
| FY2020 | $1.32 | -23.2% |
| FY2019 | $1.72 | -2.4% |
| FY2018 | $1.76 | +38.2% |
| FY2017 | $1.27 | +15.2% |
| FY2016 | $1.10 | +10.3% |
As of FY2025 · SEC 10-K · Updated Mar 14, 2026